Investing in new ideas
With targeted investments we make sure our employees have the equipment and skills they need to work on cutting-edge innovations. On top of our investments in research we also make it our priority to create an open-minded atmosphere at our company – through open processes, co-operations, alliances and partnerships. Find out more about our approach to innovation, research and development here.
Our
sustainability report
We transparently inform our stakeholders about our activities and successes, along with the challenges we face. Every year, we publish a comprehensive report on our progress, goals and efforts worldwide.
Facts & Figures
-
2.4
billion EUR investment in R&D in 2023
-
11,6%
of Total Sales invested in R&D in 2023
.
Our R&D Approach
Our research scientists are hard at work on groundbreaking medicines and technologies to treat diseases from cancer to multiple sclerosis. Wherever there is a medical need, our highly experienced research and development team hopes to meet it.
Learn moreOur Pipeline provides information about what our Healthcare business is currently working on.
View PipelineOur Life Science business is research driven and innovation focused. In 2023, we invested 396m Euro in R&D which supported our innovation in launching new products – products designed in mind with meeting our customers most unmet needs – from antibodies to water purification systems. The ability to innovate is the core of our culture across all three of our businesses; Research Solutions, Process Solutions and Applied Solutions.
Learn moreOur Electronics business is an innovation leader, constantly producing new technologies and new markets for our customers, often through partnerships across industries. We have come up with groundbreaking semiconductor technologies and display materials.
Learn more